Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “NASH - Nonalcoholic Steatohepatitis; NAFLD - Nonalcoholic Fatty Liver Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05419765
What this trial is testing

Lysosomal Acid Lipase Activity in Nonalcoholic Fatty Liver Disease

Who this might be right for
Non-Alcoholic Fatty Liver Disease
University of Roma La Sapienza 316
Not applicableStudy completedNCT02148471
What this trial is testing

Fatty Acids, Genes and Microbiota in Fatty Liver

Who this might be right for
Nonalcoholic Fatty Liver DiseaseSteatosisNonalcoholic Steatohepatitis
Johane Allard 205
Not applicableStudy completedNCT03211299
What this trial is testing

Determinants of Liver Fat Composition

Who this might be right for
Fatty Liver, NonalcoholicInsulin Sensitivity
Maastricht University Medical Center 19
Testing effectiveness (Phase 2)UnknownNCT05084404
What this trial is testing

Efficacy and Safety of Guanabenz for Nonalcoholic Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty LiverNonalcoholic Steatohepatitis
Yokohama City University 29
Testing effectiveness (Phase 2)Study completedNCT06482112
What this trial is testing

Alternate Dosing Study of MK-6024 in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) (MK-6024-016)

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseNon-alcoholic Fatty Liver DiseaseNonalcoholic Fatty Liver Disease+1 more
Merck Sharp & Dohme LLC 124
Large-scale testing (Phase 3)Study completedNCT07278128
What this trial is testing

Evaluation of the Therapeutic Effects of Curcumin on Changes in Lipid, Metabolic, and Hormonal Profiles, Liver Enzyme Activity, and Ultrasonography Morphology of the Liver in Women With Polycystic Ovary Syndrome and Nonalcoholic Fatty Liver Disease: A Double-blind, Placebo-controlled Clinical Trial

Who this might be right for
Polycystic Ovary Syndrome (PCOS) With Concurrent Nonalcoholic Fatty Liver Disease (NAFLD)
Fateme Moshirenia 74
Not applicableLooking for participantsNCT07083336
What this trial is testing

Liver Fat as a Dietary Target of the Chinese Medical Nutrition Therapy (CMNT) Diet for Treating Type 2 Diabetes With Nonalcoholic Fatty Liver Disease (Version 3.0)

Who this might be right for
Type 2 Diabetes MellitusMetabolic Dysfunction-associated Steatotic Liver Disease
State Key Laboratory of Subhealth Intervention Technology 120
Not applicableStudy completedNCT05309642
What this trial is testing

Nonalcoholic Fatty Liver Disease - Intermittent Calorie Restriction (FLICR) Study

Who this might be right for
Nonalcoholic Fatty LiverNonalcoholic Steatohepatitis
Ewha Womans University Mokdong Hospital 72
Not applicableEnded earlyNCT05423327
What this trial is testing

Genetic Data Collection in Adult Participants to Identify Genetic Variants of Known Importance in Non-alcoholic Steatohepatitis (NASH)

Who this might be right for
Non-alcoholic Steatohepatitis (NASH)
Regeneron Pharmaceuticals 5,311
Testing effectiveness (Phase 2)Study completedNCT00885313
What this trial is testing

Effects of Docosahexaenoic Acid (DHA) on Children With Nonalcoholic Fatty Liver Disease (NAFLD)

Who this might be right for
Fatty LiverLiver FibrosisObesity+2 more
Bambino Gesù Hospital and Research Institute 60
Testing effectiveness (Phase 2)WithdrawnNCT04109742
What this trial is testing

Curcumin for Pediatric Nonalcoholic Fatty Liver Disease

Who this might be right for
NAFLD - Nonalcoholic Fatty Liver DiseaseNASH - Nonalcoholic Steatohepatitis
Columbia University
Not applicableStudy completedNCT01446276
What this trial is testing

Long-term Investigation of Resveratrol on Fat Metabolism in Obese Men With Nonalcoholic Fatty Liver Disease

Who this might be right for
ObesityNonalcoholic Fatty Liver Disease
University of Aarhus 26
Not applicableStudy completedNCT03289897
What this trial is testing

Non-invasive Rapid Assessment of NAFLD Using Magnetic Resonance Imaging With LiverMultiScan

Who this might be right for
NASH - Nonalcoholic SteatohepatitisNAFLDMetabolic Syndrome
Perspectum 801
Not applicableStudy completedNCT03593343
What this trial is testing

Hepatic Glycogen and Fat Oxidation

Who this might be right for
Fatty Liver, NonalcoholicMeal TimeFasting+1 more
Maastricht University Medical Center 11
Testing effectiveness (Phase 2)UnknownNCT02574325
What this trial is testing

Assess ARI-3037MO on Hepatic Fat Metabolism in Patients With Dysglycemia and Evidence of Hepatic Steatosis

Who this might be right for
Nonalcoholic Steatohepatitis
Arisaph Pharmaceuticals Inc 11
Large-scale testing (Phase 3)UnknownNCT04308980
What this trial is testing

Safety and Tolerability of Novel Medical Nutrition Products for NAFLD Treatment

Who this might be right for
NAFLDNASH - Nonalcoholic Steatohepatitis
Russian Academy of Medical Sciences 45
Not applicableStudy completedNCT02083367
What this trial is testing

Default Mode Network fMRI Maps as a Predictive Index of Hepatic Encephalopathy Outcome

Who this might be right for
Hepatic EncephalopathyCirrhosisNonalcoholic Steatohepatitis+1 more
OSF Healthcare System 12
Large-scale testing (Phase 3)Not Yet RecruitingNCT07693777
What this trial is testing

A Phase III Study to Evaluate the Efficacy and Safety of of DR10624 in Subjects With Severe Hypertriglyceridemia

Who this might be right for
Severe Hypertriglyceridemia (sHTG)Hypertriglyceridemia
Zhejiang Doer Biologics Co., Ltd. 480
Testing effectiveness (Phase 2)Study completedNCT04618744
What this trial is testing

Assess the Safety and Efficacy of Oral Insulin in T2DM Patients With Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
Diabetes Mellitus, Type 2NASH - Nonalcoholic Steatohepatitis
Oramed, Ltd. 32
Not applicableStudy completedNCT01045499
What this trial is testing

LAGB as a Treatment for Morbid Obesity in Adolescents

Who this might be right for
Morbid ObesityObstructive Sleep Apnea SyndromeMetabolic Syndrome+2 more
Jeffrey L Zitsman, MD 137
Next Page